Small Fiber Neuropathy
28
4
4
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.1%
2 terminated out of 28 trials
86.7%
+0.2% vs benchmark
7%
2 trials in Phase 3/4
38%
5 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (28)
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies
Reference Values of Intraepidermal Nerve Fiber Density in Children and Small Fiber Neuropathy in Neurodevelopmental Disorders
Detection of Small Fiber Neuropathy Using Skin Properties
Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry
Diabetes, Falls, and Fractures
Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes
Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration
Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study
IVIG in Painful Sensory Neuropathy
Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders
IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3
Chronic Pain Rehabilitation in Patients With Small Fiber Neuropathy
Biometric and Biological Data for Diagnosis and Therapy of Pain Patients
fMRI-study in Patients With Small Fiber Neuropathy
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy
Establishing Normative Values for Thermal Detection and Pain Threshold Established by the Psi Method
Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan
Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy